Sumitomo Pharma Co., Ltd.
Works in ENT · GI & liver · Hematology · Immunology · Infectious disease · Neurology · Oncology · Psychiatry · Respiratory
Sumitomo Pharma Co., Ltd. is a clinical trial sponsor. It has no active clinical trials as lead sponsor; its trials since 2021 were across 9 therapeutic areas. Since 2021 it has completed 21 trials and stopped 3 early.
Trial track record · since 2021
Pipeline · 0 active trials
No active trials with this company as lead sponsor.
Questions about Sumitomo Pharma Co., Ltd
Sumitomo Pharma Co., Ltd has no active clinical trials as lead sponsor on ClinicalTrials.gov. Since 2021 it has completed 21 trials and stopped 3 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Sumitomo Pharma Co., Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-04-17.
Approve Suite is not affiliated with Sumitomo Pharma Co., Ltd.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.